IP Library Granted Patent US 9,204,828
Granted Patent B2
US 9,204,828 · App. 13/306,335 · Granted Dec 8, 2015

Continuous blood glucose monitor

Inventors: Daniel Rogers Burnett (San Francisco, CA); Alejandro Covalin (Culver City, CA)
Assignee: TheraNova, LLC
A61B5/14532A61B5/1455A61B5/1459A61B5/1473A61B5/14865A61B5/4839
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,204,828
App. No.
13/306,335
Granted
Dec 8, 2015
Kind
B2
Abstract

A device may be implanted subcutaneously with an attached catheter inserted within, e.g., the peritoneal cavity of a subject. The catheter and/or device may also be inserted into another space, e.g., subcutaneous, vascular, peritoneal, cerebrospinal, pleural spaces, etc. The peritoneal fluid which normally collects and/or flows through the peritoneal cavity may be detected by the catheter and analyzed via the device to detect the concentration of glucose within the fluid.

Claims (40)

1. A method of determining a physiologic parameter within a body cavity, comprising:

implanting a sensor assembly subcutaneously and a catheter within a peritoneal cavity of a subject, wherein the catheter is coupled to the assembly and includes a sensor at the distal end of the catheter;

drawing a peritoneal fluid from within the peritoneal cavity into the catheter and in fluid contact with the sensor;

sensing the peritoneal fluid with the sensor;

determining, a concentration of an analyte from the peritoneal fluid with a detector programmed to receive a signal from the sensor; and

flushing the sensor periodically with fluid introduced through the catheter.

2. The method of claim 1 wherein the fluid is drawn from within the peritoneal cavity.

3. The method of claim 1 wherein determining comprises determining a concentration of glucose from the peritoneal fluid.

4. The method of claim 1 further comprising clearing the sensor in vivo via a valve tip.

5. The method of claim 4 wherein clearing, comprises actuating the sensor to move relative to the valve tip thereby clearing the sensor.

6. The method of claim 1 wherein flushing comprises flushing the sensor with the fluid from a fluid reservoir in fluid communication with the catheter.

7. The method of claim 6 wherein the fluid reservoir is implanted in the subject.

8. The method of claim 1 further comprising infusing a therapeutic fluid into the subject based upon the concentration of the analyte.

9. The method of claim 1 wherein the peritoneal fluid is drawn into the catheter using a pump.

10. A method of treating a patient with insulin, comprising:

implanting a catheter having a sensor within a peritoneal cavity of a subject, wherein the sensor is at the distal end of the catheter;

drawing a peritoneal fluid from within the peritoneal cavity into the catheter and in fluid contact with the sensor;

sensing the peritoneal fluid with the sensor;

determining a concentration of glucose from the peritoneal fluid with a detector programmed to receive a signal from the sensor;

infusing insulin into the peritoneal cavity based upon the concentration of glucose; and

flushing the sensor periodically with fluid introduced through the catheter.

11. The method of claim 10 wherein implanting comprises placing a sensing assembly subcutaneously within the subject, where the sensing assembly is coupled to the catheter.

12. The method of claim 10 further comprising clearing the sensor in vivo via a valve tip.

13. The method of claim 12 wherein clearing comprises actuating the sensor to move relative to the valve tip thereby clearing the sensor.

14. The method of claim 10 further comprising flushing the sensor with the fluid from a fluid reservoir in fluid communication with the catheter.

15. The method of claim 14 wherein the fluid reservoir is implanted in the subject.

16. The method of claim 10 wherein the peritoneal fluid is drawn into the catheter using a pump.

17. The method of claim 10 wherein the fluid is drawn from within the peritoneal cavity.

18. A method of determining a physiologic parameter within a body cavity, comprising:

implanting a sensor assembly subcutaneously and a catheter within a peritoneal cavity of a subject, wherein a sensor is at the distal end of the catheter;

infusing a semipermeable membrane of the catheter with peritoneal fluid from within the peritoneal cavity wherein the peritoneal fluid comprises an analyte;

determining a concentration of the analyte diffused through the semipermeable membrane with a detector programmed to receive a signal from the sensor; and

flushing the sensor periodically with fluid introduced through the catheter.

19. The method of claim 18 wherein the fluid is drawn from within the peritoneal cavity.

20. The method of claim 18 wherein determining comprises determining a concentration of glucose from the peritoneal fluid.

21. The method of claim 18 further comprising clearing the sensor in vivo via a valve tip.

22. The method of claim 21 wherein clearing comprises actuating the sensor to move relative to the valve tip thereby clearing the sensor.

23. The method of claim 18 further comprising flushing the sensor with the fluid from a fluid reservoir in fluid communication with the catheter.

24. The method of claim 23 wherein the fluid reservoir is implanted in the subject.

25. The method of claim 18 further comprising infusing insulin into the subject based upon the concentration of the analyte.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2012
From: BURNETT, DANIEL R.; COVALIN, ALEJANDRO
To: THERANOVA, LLC
Reel/Frame 027861/0005 →
Continuity (4)
Continuation PCTUS2010036950 · Jun 1, 2010
Provisional Application 61217537 · Jun 1, 2009
Provisional Application 61337648 · Feb 11, 2010
Related Publication 20120165641A1 · Jun 28, 2012